Wall Street’s sell-off is easing up following a scary stretch where worries about the economy and tariffs sent it close to 9% ...

The U.S. stock market’s sell-off is worsening Monday, and it’s heading toward its worst day since 2022 as Wall Street questions how much pain President Donald Trump is willing for the economy to ...

Wall Street’s sell-off is easing up following a scary stretch where worries about the economy and tariffs sent it close to 9% ...

Kathleen Borthwick, the Chief Financial Officer of Passage BIO, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company currently valued at $32.66 million, recently executed... Passage Bio ...

53.48% of the stock is currently owned by hedge funds and other institutional investors. In other Passage Bio news, major shareholder Orbimed Advisors Llc sold 54,181 shares of the stock in a ...

The company has a market capitalization of $29.03 million, a P/E ratio of -0.40 and a beta of 1.55. The stock’s 50 ... Receive News & Ratings for Passage Bio Daily - Enter your email address ...